Le big business du typage de HPV

By |2019-06-11T11:40:41+00:00avril 2nd, 2017|Categories: Conflits d'intérêts - Conflict of interest, Surdiagnostic - Overdiagnosis, Typage de HPV - HPV testing, Vaccination anti-HPV - HPV vaccine|

Abstract: HPV testing is now recommended in several countries (In Holland and USA, for example) to replace the Pap test (cytology) for primary screening of cervical cancer. Roche is one of the big players in this field with its cobas® HPV test. The marketing of the new version was announced on March 28, 2017. The market [...]